Cardiology Consultants of Philadelphia (CCP), the largest independent Cardiology group in the United States, and CleveMed, a leading manufacturer of Home Sleep Testing (HST) equipment and web-based solutions, recently announced the launch of a new sleep disorders program at CCP to reduce cost and improve access to sleep apnea diagnosis and treatment. A significant percentage of the patients seen at cardiology practices have sleep apnea due to the strong link between sleep disorders and many cardiac conditions. However, the majority of the patients remain undiagnosed and untreated due to the cost and inconvenience of in-laboratory based testing. Physicians at CCP will now be able to identify patients suspected of Obstructive Sleep Apnea (OSA) and initiate a sleep study in the comfort of their own home using CleveMed’s SleepView Monitor and Web Portal technologies. Diagnostic reports generated by local sleep specialists allow CCP physicians to start treatment or coordinate follow-up care quickly. In addition to convenience and cost savings of diagnosis, which is expected to be more than 75%, sleep apnea treatment has been shown to improve cardiac disease, further emphasizing the need to identify and treat OSA patients seen in cardiology practices
“CCP has defined itself over the years as being a leader in providing our patients with state-of -the-art technology in an outpatient setting,” said Mark Victor, MD, CCP CEO. “We offer the entire spectrum of outpatient services, from basic preventative care to on-site noninvasive diagnostic imaging. Top quality care is consistent across all of our 27 locations. Our decision to partner with CleveMed, a recognized leader in Home Sleep Testing, meets CCP’s goal of providing our patients with efficient, cost-effective, high quality care in a convenient location. We specialize in patient focused care to optimize each patient’s needs.”
“We are happy to be the diagnostic partner for CCP’s Home Sleep Testing Program,” said Kirk Scovill, CleveMed national sales director. “The flexibility of our web-portal will allow for all of CCP’s offices to connect with local sleep specialists and treatment providers in order to provide an effective continuum of care to their patients.”
“CleveMed’s HST web-based platform is growing rapidly nationwide. Our partnership with CCP is particularly exciting because it aims to lead the nation in incorporating sleep apnea services within cardiac care. This program promises to help thousands of patients because it is convenient, inexpensive, and can improve outcome”, said Hani Kayyali, CleveMed president.
The SleepView Monitor is the market’s smallest and lightest type three portable home sleep monitor. It allows patients to be tested for OSA in the comfort, convenience and privacy of their own home. The SleepViewSM Web Portal provides prescribing physicians with secure, HIPAA compliant online access to sleep study reports generated by board certified sleep physicians, and a pathway to initiate various treatments. Sleep apnea is the repeated stoppage of breathing during the night, which can severely disrupt patient’s sleep. Sleep Apnea affects more than 40 million patients and the vast majority of sufferers remain undiagnosed and untreated.
For more information, please visit www.CleveMed.com.
